SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?


To: QuietWon who wrote (25247)12/10/1998 6:01:00 AM
From: NoWhereMan  Respond to of 119973
 
Reminder about ASTM's position on stem cell therapy:

fpinc.com



To: QuietWon who wrote (25247)12/10/1998 10:13:00 AM
From: TheAlaskan  Respond to of 119973
 
QuietWon

There are many references on services stating that the reason for higher losses in 1998 was an end of a research agreement with Rhone-Poulenc Rorer. I will call the company later and get more on this. It is good to know that Cobe will be distributing ASTM products and that they licensed the patents from Univeristy of Michigan.

Regardless, ASTM will play till the 12th. There will be media big time at the conference in Seattle. Hopefully ASTM will send its PR folks to handle the press while the science folks dazzle the conference attendees.

Along for the ride.

The Alaskan